BETHESDA, Md., Jan. 31, 2024 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today releases the following letter.
Gain Therapeutics (GANX) CEO issues Letter to Shareholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Profitability This table compares KalVista Pharmaceuticals and […]
Gain Therapeutics: The Case For GCase In Parkinson s And Buyout Potential (NASDAQ:GANX) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Presentation will highlight new data of GT-02287 in preclinical models of Parkinson’s diseaseBETHESDA, Md., Jan. 02, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company.